Diplomate American College of Veterinary Internal Medicine (Oncology)
Diplomate American College of Veterinary Radiology (Radiation Oncology)
1997, DVM, University of California, Davis, CA
1988, BA, Boston University, Boston
2006, MAS, University of California, Davis, CA
Active Research Grants
Co-Principal Investigator, Development of PET Imaging Biomarkers to Predict Enhanced Glioblastoma Radiotherapy by a Novel H-NOX Oxygen Carrier, Cherry/Kent/Krtolica/Zwingenberger, MPI (Principal Investigator), NCI
Co-Investigator, Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers, Canter/ Rebhun, MPI (Principal Investigator), NIH/NCI
Principal Investigator, Machine learning to predict organ motion in dogs undergoing radiation therapy to predict organ motion in dogs undergoing radiation therapy - Cayuse A20-3845 , (Principal Investigator), Varian Medical
Principal Investigator, Using CDA Technology to Detect Cancer and Assess Remission Status in Dogs , (Principal Investigator), Anpac Biomedical Technology
Most Recent Five Book Chapters
2019 Bergman PJ., Selmic LE and Kent MS: Chapter 20: Melanoma, Vail, D., Tham, D., & Liptak, J., (ed), Withrow and MacEwen's Small Animal Clinical Oncology, 6th edition. , . .
2014 Kent MS, Seguin B: Oral Tumors, Bonagura JD, Twedt DC, (ed), Current Veterinary Therapy XV, St. Louis, MO. 366-69.
2012 Bergman PJ, Kent MS, Farese J: Melanoma, Withrow, Vail, (ed), Withrow and MacEwen's Small Animal Clinical Oncology, 5th Edition, St. Lois, MO. 321-33.
2012 Kent MS, Primas P: Chapter 63, Safe handling and care of patients exposed to radioactive and antineoplastic agents, Burkitt Creedon JM, Davis H, (ed), Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care, 1st Edition, Ames, Iowa. 814-20.
2008 Holmberg BJ, Kent MS: Ocular neoplasia, Bonagura JD, Twedt DC, (ed), Kirk's Current Veterinary Therapy XIV, St. Louis. 1153-7.
Clinical and technical aspects of Radiation Oncology and targeted therapies.